바이오의약품 수탁제조 시장(2022-2032년) : 원료, 서비스, 제품, 기업 규모, 운영 규모, 지역 및 주요 국가별 시장 분석, 주요 기업, COVID-19 회복 예측
Biopharmaceuticals Contract Manufacturing Market Report 2022-2032: Forecasts by Source, by Service, by Product, by Company Size, by Scale of Operations, Regional & Leading National Market Analysis, Leading Companies, and COVID-19 Recovery
상품코드 : 1062709
리서치사 : Visiongain Reports Ltd.
발행일 : 2022년 01월
페이지 정보 : 영문 659 Pages
£ 3,999 ₩ 6,323,000
Unprintable PDF (Single User) - 1 Year License help
1명만 이용할 수 있는 라이센스입니다. DRM(디지털 저작권 관리 시스템) 장착 PDF 파일로, 인증된 PC 1대에서만 열람이 가능하며, 구입일로부터 1년간 유효합니다. PDF 파일은 Copy & Paste 가 되지 않으며, 인쇄 또한 불가능합니다.
£ 4,500 ₩ 7,116,000
PDF (Team License - Up to 6 Users) - 1 Year License
£ 5,500 ₩ 8,697,000
PDF (Site License) help
동일 사업장(소재지) 내 모든 분이 이용할 수 있는 라이센스입니다. 이용 인원수 제한은 없습니다. PDF 파일은 Copy & Paste 가 되지 않습니다. DRM(디지털 저작권 관리시스템)은 적용되어 있지 않지만, PDF 인쇄는 1명당 1회에 한해 가능합니다. 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
£ 6,999 ₩ 11,067,000
PDF (Enterprise License - Includes Free Datasets)

주의 : 본 보고서는 DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로, 라이선스에 따라 자료 이용 및 인쇄 등에 제약이 있을 수 있습니다. 자세한 내용은 라이선스 설명문( )을 참고하여 주시기 바랍니다.



한글목차

미국은 바이오의약품 비지니스에서 세계를 선도하고 있으며, 세계의 '생명과학 혁신 캐피탈'로 불리며 바이오의약품의 중요한 투자국이 되고 있습니다. 바이오의약품의 수요 증가는 미국 바이오의약품 업계의 확대를 지원하는 것으로 생각되고 있습니다.

또한 COVID-19 팬데믹에 의해 인도의 바이오의약품 부문이 각광을 받고 있습니다. 인도의 바이오테크놀러지 산업은 새로운 성장 단계를 맞이하고 있으며, 사람들의 생활에 접하여 개선하기 위한 큰 가능성을 내포한 산업으로서 세계 각국으로부터 높은 평가를 받고 있습니다.

세계의 바이오의약품 수탁제조 시장에 대해 조사했으며, 시장 규모 및 예측, 시장 역학, 부문·지역별 시장 분석, 시장 점유율, 경쟁 구도, 주요 기업의 개요 등의 정보를 정리하여 전해드립니다.

샘플 뷰

목차

제1장 리포트의 개요

제2장 개요

제3장 시장 역학

제4장 원료별 : 바이오의약품 수탁제조 시장

제5장 서비스별 : 바이오의약품 수탁제조 시장

제6장 제품별 : 바이오의약품 수탁제조 시장

제7장 기업 규모별 : 바이오의약품 수탁제조 시장

제8장 운영 규모별 : 바이오의약품 수탁제조 시장

제9장 지역 및 주요 국가의 바이오의약품 수탁제조 시장 예측(2022-2032)

제10장 북미의 바이오의약품 수탁제조 시장

제11장 유럽의 바이오의약품 수탁제조 시장

제12장 아시아태평양의 바이오의약품 수탁제조 시장

제13장 라틴아메리카의 바이오의약품 수탁제조 시장

제14장 중동·아프리카의 바이오의약품 수탁제조 시장

제15장 기업 개요

제16장 결론과 제안

KSA 22.04.06
영문 목차

영문목차

Title:
Biopharmaceuticals Contract Manufacturing Market Report 2022-2032
Forecasts by Source (Mammalian, Non-mammalian), by Service (Process Development (Downstream, Upstream), Fill & Finish Operations, Analytical & QC Studies, Packaging), by Product (Biologics (Monoclonal Antibodies (MABs), Recombinant Proteins, Vaccines, Antisense, RNAi, & Molecular Therapy, Others), Biosimilars), by Company Size (Small, Mid-sized, Large), by Scale of Operations (Preclinical, Clinical, Commercial) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Recovery Scenarios.

Biopharmaceuticals Contract Manufacturing Market, 2022 to 2032- our new study reveals the latest industry trends, R&D progress, and predicted revenues

The U.S. is the Global Leader in Biopharmaceutical Business

The United States has been dubbed the "life sciences innovation capital" of the world, and it is a significant biopharmaceutical investor. The increased demand for biologics is likely to boost the expansion of the US biopharmaceuticals industry.

In terms of economic contributions and overall impacts, the biopharmaceutical sector in the United States is not only a worldwide leader in the development of innovative medicines, vaccines, and diagnostics, but it is also a highly valued industry. With a diverse employment base and vast research, manufacturing, and distribution infrastructure, the biopharmaceutical business in the United States is a major and innovative component of the country's economy, with considerable influence on economies around the country.

There is a vast innovation ecosystem in the biopharmaceutical industry that drives and maintains this success. An extensive network of collaborators supports the discovery, development, and delivery of new medicines to patients through this innovation ecosystem, which is led by both small and large R&D-intensive companies. This network includes but is not limited to venture and other forms of private capital; health care providers; public and private sector researchers including academic medical researchers and private research institutes; and various other sectors. A strong biopharmaceutical innovation ecosystem and innovation-based policy make the United States the world leader in biopharmaceutical innovation. All these factors are anticipated to fuel the biopharmaceutical contract manufacturing market in the United States.

COVID-19 pandemic has brought India's Biopharmaceuticals Sector into the Limelight

The Indian biotechnology industry has entered a new phase of growth, with the rest of the world increasingly appreciating the sector's enormous potential to touch and improve people's lives. In the middle of the pandemic, the successful production of contingent commodities like the Covid-19 vaccine and indigenous diagnostic kits in such a brief period has been a wonderful benefit to humanity. The Biotechnology Industry Research and Development Corporation (BIRAC) and the Department of Biotechnology (DBT) have been at the forefront of enhancing the country's creative talents and potential.

The development of alternative Covid 19 solutions has been hastened by the Government of India's Mission program COVID Suraksha and the Covid-19 Research Consortium, which is led by DBT and BIRAC. With significant contributions from different states, the nation is on its way to becoming a globally renowned Innovation Hub and Biomanufacturing Hub. Official Biotech policies are in existence or being developed in several states. It is the responsibility of the Department of Biotechnology's Make In India (MII) Facilitation Cell, based at BIRAC alongside Invest India, to interact with States and assist them in formulating biotech policies, promote direct foreign investment, and improve the manufacturing sector, among other things.

What are the Market Driversw

What are the Market Opportunities?

Discover how to stay ahead

Our 650+ page report provides 700+ tables and charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at the overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Biopharmaceuticals Contract Manufacturing Market. See how to exploit the opportunities.

Forecasts to 2032 and other analyses reveal the commercial prospects

Discover sales predictions for the world market and sub-markets

Source

Service

Product

Company Size

Scale of Operations

Region

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 17 leading national markets:

By Region

Leading companies and the potential for market growth

Overall world revenue for Biopharmaceuticals Contract Manufacturing Market will surpass US$xx billion in 2022, our work calculates. We predict strong revenue growth through 2032. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Biopharmaceuticals Contract Manufacturing Market report helps you

In summary, our 650+ page report provides you with the following knowledge:

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else

With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the Biopharmaceuticals Contract Manufacturing Market and leading companies. You will find data, trends, and predictions.

Table of Contents

1. Report Overview

2 Executive Summary

3 Market Dynamics

4 Biopharmaceuticals Contract Manufacturing Market by Source

5 Biopharmaceuticals Contract Manufacturing Market by Service

6 Biopharmaceuticals Contract Manufacturing Market by Product

7 Biopharmaceuticals Contract Manufacturing Market by Company Size

8 Biopharmaceuticals Contract Manufacturing Market by Scale of Operations

9 Regional and Leading National Biopharmaceuticals Contract Manufacturing Market Forecasts 2022-2032

10 North America Biopharmaceuticals Contract Manufacturing Market

11 Europe Biopharmaceuticals Contract Manufacturing Market

12 Asia Pacific Biopharmaceuticals Contract Manufacturing Market

13 Latin America Biopharmaceuticals Contract Manufacturing Market

14 Middle East and Africa Biopharmaceuticals Contract Manufacturing Market

15 Company Profiles

16 Conclusion and Recommendations

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기